Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Syneron Medical Ltd (NASDAQ:ELOS)

9.04
Delayed Data
As of 12:49pm ET
 -0.05 / -0.55%
Today’s Change
8.32
Today|||52-Week Range
12.90
-3.11%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$332.0M

Company Description

Syneron Medical Ltd. engages in the provision of aesthetic medical business. Its activities include design, development and marketing of aesthetic medical products using technologies such as Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency, or RF energy, and optical energy. Its devices covers a range of solutions including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis and topical skin brightening products. Its offers its products among physicians and other practitioners. The company was founded by Shimon Eckhouse and Moshe Mizrahy in July 2000 and is headquartered in Yokneam Illit, Israel.

Contact Information

Syneron Medical Ltd.
Tavor Building 4
Yokneam Illit Haifa 20692
P:972732442200
Investor Relations:

Employees

Shareholders

Other institutional56.05%
Mutual fund holders17.87%
Individual stakeholders--

Top Executives

Amit MeridorPresident & Chief Executive Officer
Shlomo AlkalayChief Operating Officer
Hugo GoldmanChief Financial Officer
Jonathan T. PearsonExecutive VP-Topical Products Business Development
Sarit Soccary Ben YochananVice President-Strategy & Business Development